A Study of Serum Folate Levels in Patients Treated With Olaparib
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a study investigating folate deficiency (lack of folic acid in the blood) in patients
who take the drug olaparib to treat their advanced ovarian or breast cancer. The primary goal
of this study is to determine the frequency and timing of folate deficiency, and to learn
more about whether giving folic acid supplements (vitamins) will help delay or avoid
deficiency in these patients. Deficiency can cause doctors to reduce or stop treatment with
olaparib. In this case, patients are not getting the best treatment for their cancer due to
the unwanted side effect.